Hua Medicine's non-executive director, Dr. Fangxin Li, resigns
Hua Medicine (HKEX:2552) announced the resignation of Dr. Fangxin LI as a non-executive Director and a member of the Remuneration Committee, effective June 25, 2025. The company stated that the resignation is due to Dr. LI's personal work arrangement. The Board indicated that there were no disagreements or matters related to his resignation that needed to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. Hua Medicine expressed its gratitude to Dr. LI for his contributions during his tenure.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Hua Medicine publishes news
Free account required • Unsubscribe anytime